High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702)-Reference-Cited by-同舟云学术

High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702)

Published:2016-05-20 Issue:9 Volume:63 Page:1563-1570
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Nazemi Kellie J.¹,Shen Violet²,Finlay Jonathan L.³⁴,Boyett James⁵,Kocak Mehmet⁶,Lafond Deborah⁷,Gardner Sharon L.⁸,Packer Roger J.⁹,Nicholson H. Stacy¹¹⁰

Affiliation:

1. Division of Pediatric Hematology-Oncology; Department of Pediatrics; Doernbecher Children's Hospital; Oregon Health & Science University; Portland Oregon

2. Children's Hospital of Orange County; Cancer Institute; Orange California

3. Children's Hospital of Los Angeles; Neuro-Oncology Program; Los Angeles California

4. Division of Hematology, Oncology and BMT; Nationwide Children's Hospital; Columbus Ohio

5. Department of Biostatistics; Saint Jude Children's Research Hospital; Memphis Tennessee

6. Department of Preventive Medicine; University of Tennessee Health Science Center; Memphis Tennessee

7. Department of Hematology-Oncology; Children's National Health System; Washington District of Columbia

8. Hassenfeld Children's Center, Langone Medical Center; New York University; New York New York

9. Center for Neuroscience and Behavioral Medicine; Brain Tumor Institute; Washington District of Columbia

10. Department of Child Health; University of Arizona and Phoenix Children's Hospital; Phoenix Arizona

Funder

Children's Cancer Group and subsequently Children's Oncology Group (COG)

National Cancer Institute COG Chairman's Grant

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference50 articles.

1. Embryonal Tumors

2. Histopathologic grading of medulloblastomas;Eberhart;Cancer,2002

3. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia;Eberhart;J Neuropathol Exp Neurol,2004

4. Metastasis stage, Adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the children's cancer group 921 Randomized phase III study;Zeltzer;J Clin Oncol,1999

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches;Diagnostics;2023-12-16

2. Questions and answers in the management of children with medulloblastoma over the time. How did we get here? A systematic review;Frontiers in Oncology;2023-06-29

3. Meta of classical chemotherapy compared with high-dose chemotherapy and autologous stem cell rescue in newly diagnosed medulloblastoma after radiotherapy;Medicine;2022-07-29

4. Tandem autologous hematopoietic stem cell transplantation for embryonal brain tumors in infants and very young children;Bone Marrow Transplantation;2022-02-03

5. High-risk Medulloblastoma—Balancing the High Stakes of Molecular Profiling to Enhance Treatment Responsivity;JAMA Oncology;2021-09-01